Abstract
This observational study reports on a comprehensive nationwide evaluation of rising gastroenteropancreatic neuroendocrine tumor incidence in the US from 2001 to 2020.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have